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ABSTRACT 
Naishal Patel: The Effects of Arsenic and Heavy Metal Mixtures on Pancreatic β-cell Insulin 
Secretion 
(Under the direction of Dr. Miroslav Styblo)  
 
 Diabetes mellitus is a known metabolic disorder characterized by altered insulin secretion or 
responsiveness. Recently, a potential association between diabetes and environmental exposures has been 
described, in which environmental compounds have been identified as potential diabetogens. With 
diabetes prevalence and industrial growth rising in many middle- and low-income countries, it is 
imperative we look further into the association between heavy metals and diabetes mellitus. Interactions 
between iAsIII and heavy metals may exhibit differing effects on insulin secretion machinery than just 
individual heavy metals.  In previous studies, trivalent inorganic arsenic (iAsIII) has been identified as an 
inhibitor of insulin secretion in isolated mouse islets. In addition to iAsIII, heavy metals, notably zinc (Zn), 
manganese (Mn) and cadmium (Cd), have also been found to be associated with alteration of insulin 
secretion. INS-1 (832/13) rat insulinoma cells were treated for 24 hours with varying concentrations of 
each of the aforementioned heavy metals. When co-exposed with Zn and Cd, iAsIII acted as the primary 
inhibitor of insulin secretion in the β-cells. Co-exposure of Mn and 1 μM iAsIII, exhibited a significant 
decrease in insulin secretion at the 25 and 50 μM Mn concentrations compared to 1 μM iAsIII exposure 
alone. There was no significant difference in insulin secretion between the Mn and iAsIII co-exposure and 
Mn alone treatment groups at the 25 and 50 μM Mn concentrations, suggesting Mn as a primary driver of 
insulin secretion inhibition at higher concentrations. Additionally, 24-hour 1 μM iAsIII exposure to INS-1 
(832/13) cells caused a significant decrease in mitochondrial oxygen consumption rate (OCR) under 
energy-demanding conditions, identifying mitochondria as targets for iAsIII in β-cells. This study 
examines the impact of heavy metals and their mixtures with iAsIII on insulin secretion in INS1 (832/13) 
rat pancreatic β-cells. From these results, we conclude that water mixtures containing certain heavy 
metals in mixture with iAsIII may pose significant danger to pancreatic β-cell function.  
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CHAPTER 1: INTRODUCTION 
1.1 Diabetes Mellitus 
 Diabetes mellitus (DM) is a metabolic disorder that is characterized by abnormal glucose 
homeostasis and is associated with many secondary health outcomes. Individuals living with DM 
have increased risks of many unfavorable conditions including: blindness, kidney failure, heart 
disease, stroke and loss of body extremities (CDC, 2014). DM prevalence has doubled from 
1980 to 2014 and has accounted for about 422 million deaths worldwide in 2014 (IDF, 2015). In 
2014, DM constituted 12% of global health expenditures, summing up to a grand total of $673 
billion (IDF, 2015). Currently, DM is known to be associated with various risk factors including 
obesity, lack of physical activity, unhealthy diet, high blood pressure and pro-diabetic genetic 
traits. These risk factors have been widely recognized as the major targets of diabetes prevention. 
However, some DM cases may develop as the result of environmental toxins. In order to further 
investigate this claim, research on the potential causes of DM, similar to this study, needs to 
continue in order to prevent the exacerbation of DM-related complications. 
 DM is typically characterized as either Type I or Type II. Type I diabetes is an 
autoimmune disorder primarily involving pancreatic β-cell destruction and can result in chronic 
hyperglycemia due to defects in insulin secretion. Type II diabetes also results in chronic 
hyperglycemia, but is normally caused by either insulin resistance of target tissues or diminished 
insulin release (Sivitz and Yorek, 2010).  
1.2 Pancreatic β-cell Insulin Secretion 
 The pancreatic β-cell is the primary cell type involved in insulin secretion, and its 
dysfunction plays a central role in the development of DM. The main function of the β-cell is to 
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secrete insulin in response to increased glucose loads via glucose uptake by the GLUT2 
transporter. Following uptake, glucose is metabolized via glycolysis and the tricarboxylic acid 
(TCA) cycle. The oxidative coenzymes produced, NADH and FADH2, then travel to the electron 
transport chain (ETC), where ATP synthase increases ATP production, resulting in an increased 
ATP:ADP ratio. A rise in the ATP:ADP ratio closes an ATP-sensitive K+ channel, depolarizing 
the β-cell plasma membrane. Depolarization of the plasma membrane opens voltage-gated Ca2+ 
channels, allowing extracellular Ca2+ to rush into the β-cell. Ultimately, the process ends in the 
Ca2+ ions leading to exocytosis of secretory vesicles and the release of insulin into the 
bloodstream (Antonioli et al., 2015). 
1.3 Mitochondria and Insulin Secretion 
 Recently, mitochondria have been suggested to play an important role in regulating KATP-
dependent and KATP-independent insulin secretion (Wollheim, 2000). Dysfunction in 
mitochondria, for this reason, could potentially be associated with inhibition of insulin secretion. 
A recent review has identified many environmental compounds as having a role in mitochondrial 
dysfunction (Meyer et al., 2013). Studies within the review have recognized some of the 
compounds being examined in this thesis as having some toxic effect on mitochondria in various 
cell types and include: arsenic, manganese and cadmium (Bowman et al., 2011; Dopp et al., 
2008; Garceau et al., 2010; Sokolova et al., 2005; Zheng et al., 1998). 
1.4 Arsenic 
 Arsenic (As) is a naturally-occurring toxic metalloid with no known physiological 
purpose and is one of the less abundant minerals of the Earth’s crust (Nordstrom, 2002). Arsenic 
can be found in either the organic or inorganic form, with inorganic arsenic (iAs) primarily being 
found in groundwater reservoirs and certain food sources like rice and apple juice (FDA, 2013; 
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Nriagu and Lin, 1995). Many countries including the United States of America have iAs present 
at high levels in the groundwater (WHO, 2016). Both the EPA and WHO regulations have 
agreed upon a drinking water standard for As at 10 ppb (DEP, 2012; US EPA, 2009). However, 
well water is not regulated and has been identified to have high levels of iAs in certain regions 
(González-Horta et al., 2015; Gronberg, 2011; Sanders et al., 2014). There are two oxidation 
states at which iAs is found: trivalent (iAsIII) or pentavalent (iAsV). Humans have been shown to 
reduce iAsV to iAsIII as an intermediate step during iAs metabolism, with iAsIII being more toxic 
than iAsV (Styblo et al., 2000). Many epidemiological studies have highlighted the toxic effects 
iAs may have on pancreatic β-cells ultimately resulting in their dysfunction (Liu et al., 2014) and 
have found an association between iAs exposure and DM (Mendez et al., 2016). One study has 
established a dose-dependent inhibition of insulin secretion by INS-1 (832/13) β-cells in 
response to chronic low-level iAsIII exposure (Fu et al., 2010). Additional research has indicated 
that methylated metabolites of iAs, methylarsonite (MAIII) and dimethylarsinite (DMAIII), are 
even more potent inhibitors of β-cell function (Douillet et al., 2013). Studies in other cell types 
have shown that many essential components of the insulin secretory pathway are susceptible to 
the effects of iAsIII. These targets include: GLUT2, hexokinase, dihydrolipoamide, Calpain-10 
and insulin granule exocytosis (Liu et al., 2006; Pysher et al., 2007; Tseng, 2004; Díaz-
Villaseñor et al., 2008; Turner, 2007). Research on the mechanisms of iAsIII effects on β-cells is 
limited, however, and will be further investigated in this thesis. 
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Figure 1.1: Potential Mechanisms for Arsenic Inhibition of Insulin Secretion 
1.5 Manganese 
 Manganese (Mn), a naturally occurring brittle heavy metal, is found in the Earth’s crust 
in over 100 minerals (WHO, 2004). Common environmental sources of Mn include industrial 
emissions, soil erosion and volcanic emissions, while dietary sources include mostly nuts and 
leafy vegetables (Higdon, 2001). Mn can also occur naturally in surface and groundwater due to 
Mn-rich soils (WHO, 2011a). The EPA has established a secondary drinking water standard for 
Mn at 0.05 mg/L, which many countries besides the USA have also adhered to (US EPA, 2009; 
WHO, 2011a). Studies testing groundwater levels, especially in South Asian countries, have 
found well water exceeding US-EPA limits (Akter et al., 2016; Kumar et al., 2016).  
 Due to its extensive role in the body, Mn is not treated with the same urgency as potent 
environmental toxins (i.e. As and Cd) for good reason. Within the human body, Mn serves roles 
as an activator and cofactor for many enzymes. Mn exists in either the 2+ (more common) or 3+ 
oxidation state in the body and has been shown to accumulate in specific tissues, including 
pancreatic β-cells (Rorsman et al., 1982). Not much is known regarding the specific role of Mn 
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in β-cell insulin secretion, but Mn supplementation has been shown to increase insulin secretion 
in isolated islets from C57BL/6J mice fed a high fat diet (Lee et al., 2013).  
1.6 Cadmium 
 Cadmium (Cd) is a naturally occurring heavy metal with no known physiological 
purpose. In the environment, Cd occurs as a part of Zn ores and is only found in the 2+ oxidation 
state (WHO, 2011b). Naturally, Cd is found in surface water and groundwater, but normally is 
not found in particularly high concentrations (WHO, 2011b). Nevertheless, higher Cd levels can 
be found in areas containing a large amount of Zn-galvanized pipes, Cd-containing solders, low 
pH soft water or high industrial activity (WHO, 2011b). US EPA regulations mandate Cd in 
drinking water to be limited to 5 ppb, while the WHO has 3 ppb as the guideline value for Cd in 
drinking water (US EPA, 2009; WQA, 2013). In developed countries, dietary Cd is the highest 
source of Cd exposure in the United States (WHO, 2011b). Cd in the diet is mainly obtained 
from leafy vegetables, potatoes, soybeans and sunflower seeds (CDC, 2012). Although Cd may 
not be found in particularly high concentration in many areas, it is important to consider chronic 
accumulation of the heavy metal in bodily tissues, especially the pancreas. 
 Cd over the average human’s lifespan, has been shown to accumulate in organs for 
unknown reasons. Although Cd has been shown to preferentially accumulate in the liver and 
kidneys, it has also been documented to accumulate in pancreatic β-cells (ATSDR, 2008; El 
Muayed et al., 2012). Chronic Cd accumulation in the β-cells results in inhibition of insulin 
secretion at low concentrations without significant decreases in cell viability (El Muayed et al., 
2012). This would suggest Cd has some inhibitory effects on either insulin production or 
secretion machinery after chronic exposure and is worth examining in this study. 
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1.7 Zinc 
 Zinc (Zn) is an abundant element in the Earth’s crust, which can be found either in 
surface water, groundwater or even tap water due to Zn leakage from pipes and fittings (WHO, 
2003). Zn has been limited to 5 ppm by a secondary drinking water standard by the US EPA, 
whereas the WHO does not report a specified guideline value for Zn in drinking water (US EPA, 
2009; WHO, 2011c).  
 Of Zn’s many physiological roles, some are specifically related to insulin storage and 
secretion. One of the most well-known functions of Zn in regards to insulin, is the Zn-mediated 
crystallization of insulin. Insulin crystallization allows stable storage of insulin, protecting it 
from degradation (Li, 2014). Insulin secretion has been shown to release Zn as well for paracrine 
signaling within islets (Nygaard et al., 2014). Zn is also a key functional component of Zn finger 
proteins, which assist in gene regulation of various enzymes in the majority of cells including β-
cells (Henry et al., 2014).  
 One study using the INS-1E rat pancreatic β-cell line identified 24-hour Zn 
supplementation to increase insulin secretion using physiologically relevant Zn concentrations 
(Nygaard et al., 2014). The same study then showed higher Zn concentrations inhibiting insulin 
secretion via cytotoxic effects.  
1.8 Arsenic and Heavy Metal Interaction 
 Trivalent iAs and some heavy metals, namely Zn, Mn and Cd, have been found to be 
present naturally in groundwater across the world. Although there are other methods of exposure, 
populations drinking unregulated private well water in the US and living in specific regions 
within industrializing countries are at risk for high levels of exposure to these compounds 
(Sanders et al., 2014). In the case of Cd and Mn, it is crucial to keep in mind that they have the 
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potential to accumulate in certain bodily tissues, including those of the pancreas. More 
specifically, in the insulin-secreting pancreatic β-cells. 
 In addition to understanding the effects of these compounds alone on β-cells, it is also 
imperative to recognize that these metals and metalloids may coexist as complex mixtures in 
nature. Coexistence in mixture allows for the possibility for interactions among the heavy metals 
and iAsIII, which have yet to be studied. Further research into this topic will help gather 
knowledge on whether an interaction between compounds in complex mixtures exists and if so, 
the mechanism by which it acts. This thesis will attempt to determine if Zn2+, Mn2+ or Cd2+ 
interact with iAsIII to affect INS-1 (832/13) rat pancreatic β-cell insulin secretion differently from 
that of iAsIII alone. The results from this study will aim to explain the effects of naturally 
occurring compound mixtures on pancreatic β-cells, and how they could potentially contribute to 
DM. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 INS-1 (832/13) β-cell Culture 
A rat pancreatic β-cell line, INS-1 (832/13), passage number 45-60 was used in this 
study. Cells were cultivated in RPMI 1640 medium with 10% fetal bovine serum, 10 mM Hepes, 
100 U/ml penicillin, 100 μg/ml streptomycin , 1 mM sodium pyruvate and 0.05 mM β-
mercaptoethanol (all from Sigma, St. Louis, MO) at 37°C with 5% CO2. Cells were grown in 
T75 flasks and refed every two days with complete RPMI 1640 medium until splitting. 
2.2 Treatment 
 Cells were plated at a concentration of 1,000,000 cells per well in a 12-well tissue 
culture-treated plate and were allowed to incubate for 24 hours at 37°C with 5% CO2 prior to 
treatment. For Cd exposures, cells were treated with 1 mL of 1, 2 or 5 μM CdCl2 with or without 
1 μM iAsIII. Mn exposed cells were treated with 1 mL of 12.5, 25 or 50 μM MnCl2 with or 
without 1 μM iAsIII. Cells exposed to Zn were treated with 1 mL 6.25, 25, 50 or 200 μM ZnCl2 
with or without 1 μM iAsIII. After administration of the respective treatment concentrations, cells 
were incubated at 37°C with 5% CO2 for 24 hours before analysis. All compounds used were 
from Sigma, St. Louis, MO. 
2.3 MTT Cell Viability Assay 
 INS-1 cells were plated at a concentration of 1,000,000 cells per well in a 12-well plate 
and treated for 24 hours with metals or arsenic as indicated. Following treatment, cells were 
washed with 1 mL phenol red-free RPMI 1640 media. Each well was then incubated in 1 mL 
MTT media containing 0.5 mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) in phenol red-free RPMI 1640 media containing the respective heavy metal and 
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iAs concentrations for each treatment group. Cells were placed in an incubator at 37°C and 5% 
CO2 for 1 hour. Following incubation, the MTT media was aspirated and 500 μL dimethyl 
sulfoxide (DMSO) was added to each well. The plate was allowed to sit for 20 minutes to allow 
complete dissolution of the formazan product by DMSO. Absorbance was read at 570 nm and 
corrected using a measurement at 630 nm. 
2.4 Glucose Stimulated Insulin Secretion (GSIS) Assay 
 Following 24-hour exposure to metals, a GSIS assay was performed and metal treatment 
was carried throughout the entire experiment. RPMI 1640 medium was replaced with 1 mL of 0 
mM glucose Secretion Assay Buffer (SAB) solution containing 114 mM NaCl, 4.7 mM KCl, 1.2 
mM KH2PO4, 1.16 mM MgSO4, 20 mM Hepes buffer, 2.5 mM CaCl2, 0.2% bovine serum 
albumin, 25.5 mM NaHCO3 and sterile dH2O. After washing with 1 mL 0 mM glucose SAB, 
cells were incubated in 0 mM glucose SAB for 1 hour at 37°C with 5% CO2. After incubation, 0 
mM glucose SAB medium was replaced with 1 mL 2.5 mM glucose SAB medium and incubated 
for 1 hour. Following incubation, a 500 μL sample of medium was collected after the incubation 
period and immediately stored at -20°C. Medium was then replaced with 16.7 mM glucose SAB 
medium and incubated for 2 hours. A samples of 500 μL was collected after the incubation 
period and immediately stored at -20°C. Each well was then rinsed with 1 mL DPBS, followed 
by the addition of 100 μL RIPA lysis buffer, containing protease inhibitor, to each well. Cells 
were scraped off and the lysate was then collected in Eppendorf tubes and stored at -20°C. 
Insulin concentrations of the frozen samples were determined using a Rat/Mouse Insulin ELISA 
kit (EZRMI 13-K) from Millipore Sigma (Billerica, MA).  
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2.5 Seahorse XF Mitochondrial Stress Test 
 The Seahorse XFe96 Bioanalyzer (Agilent, Santa Clara, CA) was used to measure β-cell 
mitochondrial respiration. 50,000 cells per well were plated on a 96-well Seahorse plate and 
treated as indicated above. Seahorse medium was prepared using 114 mM NaCl, 4.7 mM KCl, 
1.2 mM KH2PO4, 1.16 mM MgSO4, 20 mM Hepes buffer, 2.5 mM CaCl2, 0.2% bovine serum 
albumin, 25.5 mM NaHCO3 and sterile dH2O. All media were buffered to pH 7.40 using 1 M 
NaOH. Treated cells were placed in 0 mM glucose SAB for 40 minutes and incubated at 37°C 
with 5% CO2. The 0 mM glucose SAB was then replaced with 2.5 mM glucose SAB (without 
NaHCO3) and incubated at 37°C without CO2. The Seahorse XFe96 Bioanalyzer was then used 
to analyze the mitochondrial oxygen consumption rate (OCR) at baseline and then in response to 
sequential addition of 16.7 mM glucose SAB (without NaHCO3 and BSA), 2 μM oligomycin, 4 
μM FCCP (carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone) and 1 μM antimycin 
A/rotenone mix (all from Sigma, St. Louis, MO).  
 
Figure 2.1: Action of Seahorse Mitochondrial Stress Test Reagents. (Seahorse Bioscience, 2009) 
 Oligomycin, antimycin A and rotenone are all inhibitors of the ETC, acting at complexes 
V, III and I, respectively. FCCP, on the other hand, is an uncoupler of the inner mitochondrial 
membrane. Action by these compounds mimics certain physiological conditions and allow us to 
measure key parameters of mitochondrial respiration based on how OCR responds. 
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Figure 2.2: Seahorse XF Cell Mitochondrial Stress Test profile of mitochondrial respiration parameters. 
(Seahorse Bioscience, 2009) 
 As seen in Figure 2.2, the inhibition of ATP synthase by oligomycin allows for the 
measurement of ATP production based on the decrease in OCR. This measurement allows for 
quantification of the amount of oxygen being used for ATP synthesis but does not measure ATP 
production itself. Additionally, there is some inevitable proton leak contributing to the measured 
OCR at this point, which is accounted for after subtracting the OCR due to non-mitochondrial 
respiration. Next, uncoupling by FCCP results in the breakdown of the proton gradient across the 
inner mitochondrial membrane. The resulting massive proton influx increases OCR to the 
maximum possible value capable by the cell’s mitochondria. This condition would be analogous 
to physiological energy-demanding situations. Finally, antimycin A/rotenone administration 
results in the inhibition of complexes I and III, essentially abolishing mitochondrial OCR. The 
remaining OCR measured can be attributable to non-mitochondrial respiration. 
2.6 Statistical Analysis 
 All MTT and GSIS assay data was analyzed using Microsoft Office Excel 2013. P-values 
were calculated using a 2-tailed t-test. For MTT results, means and standard deviations were 
calculated using either n = 3 or n ≥ 2, which were obtained by testing each treatment group with 
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2 technical replicates in biological triplicate or in the case of Zn, 3 technical replicates in 
biological duplicate. Percent absorbance of the control group was checked for significant 
differences to the control group in all treatment groups (“*” or “***”) and to 1 μM iAsIII alone in 
mixture treatment groups (“a”) using a two-tailed t-test. For GSIS results, means and standard 
deviations were also calculated using n=3 from trials using the 2 technical replicates in biological 
triplicate setup. Insulin secretion of each treatment group was checked for significant differences 
in four ways: all groups to the control group (“*” or “***”), each mixture group to 1 μM iAsIII 
alone (“a”), each mixture to its identical heavy metal concentration alone (“$” or “$$$”) and 
each heavy metal concentration compared to a lower exposure level (“%”; i.e. 25 μM Mn to 12.5 
μM Mn). For Seahorse data, Wave 2.3.0 software was used for analysis. Means and standard 
deviations were calculated in Microsoft Office Excel 2013 using n=3 by testing each treatment 
group with 3 technical replicates in biological triplicate. P-values for Seahorse data were 
calculated in GraphPad Prism 7.03 using a 2-way ANOVA test. 
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CHAPTER 3: RESULTS 
3.1 MTT Assay and Cell Viability 
MTT colorimetric assays measuring cell metabolic activity were used to determine any 
changes in INS-1 (832/13) cell viability in response to 24-hour heavy metal and iAsIII exposure.   
3.1 MTT Assay and Cell Viability 
 
Figure 3.1: Effects of Cadmium on Cell Viability. 24-hour exposure to Cd in conjunction with iAsIII or alone does 
not significantly alter cell metabolism levels in INS-1 (832/13) β-cells. n ≥ 2 *p<0.05, ***p<0.001 (Metal vs. 
Control). 
 
 After Cd exposure at 1, 2 and 5 μM Cd for 24 hours, INS-1 (832/13) cells did not exhibit 
any decrease in cell metabolic activity (Figure 3.1). A 24-hour exposure to only 1 μM iAsIII 
resulted in a 19% decrease in metabolic activity of treated cells compared to the untreated group 
(Figure 3.1). There was also a 20% decrease in metabolic activity of cells chronically exposed to 
5 μM Cd + 1 μM iAsIII (Figure 3.1). There was no significant difference in cell viability levels 
14 
 
between those exposed to 1 μM iAsIII alone and those exposed to 1-5 μM Cd exposures in 
conjunction with 1 μM iAsIII. 
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Figure 3.2: Effects of Manganese on Cell Viability. 24-hour exposure to Mn in conjunction with iAsIII or alone 
does not significantly alter cell metabolism levels in INS-1 (832/13) β-cells. n = 3; *p<0.05 (Metal vs. Control). 
 
 INS-1 (832/13) cells exposed for 24 hours to Mn at 12.5, 25 and 50 μM exhibited no 
significant differences in cell metabolic activity compared to the control (Figure 3.2). A 24-hour 
exposure to only 1 μM iAsIII resulted in an 18% decrease in metabolic activity of treated cells 
compared to the untreated group (Figure 3.2). The 12.5 and 25 μM Mn and iAsIII co-exposures 
both decreased metabolic activity by 21% (Figure 3.2). There was no significant difference in 
cell viability between cells exposed to 1 μM iAsIII alone and groups co-exposed to 12.5-50 μM 
Mn and 1 μM iAsIII. 
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Figure 3.3: Effects of Zinc on Cell Viability. 24-hour exposure to Zn in conjunction with iAsIII or alone does not 
significantly alter cell metabolism levels in INS-1 (832/13) β-cells. n ≥ 2; *p<0.05 (Metal vs. Control). 
 
 INS-1 (832/13) cells exposed for 24 hours to 5 μM Zn alone exhibited a 5% decrease in 
metabolic activity compared to the control (Figure 3.3). A more pronounced decrease of 12% 
metabolic activity was observed after the chronic 200 μM Zn exposure (Figure 3.3). The 1 μM 
iAsIII exposure resulted in a 14% decrease in metabolic activity compared to the untreated group 
(Figure 3.3). Co-exposure of all tested Zn concentrations and 1 μM iAsIII did not elicit a 
significant decrease in cell viability compared to that of 1 μM iAsIII alone.   
3.2 GSIS after Arsenic and Metal Exposure 
Exposure to arsenic has been shown to elicit a dose-dependent inhibition of insulin 
secretion by pancreatic β-cells (Fu et al., 2010). In order to examine the impact of common co-
contaminant heavy metals and arsenic, a 24-hour co-exposure model was employed followed by 
a GSIS. Similar to other studies, untreated INS-1 (832/13) cells exhibited approximately a 10-
16 
 
fold response to high glucose incubation (16.7 mM glucose) from basal low glucose incubation 
(2.5 mM glucose) (Figures 3.4-3.6). 
 
Figure 3.4: Glucose Stimulated Insulin Secretion following 24-hour exposure to iAsIII and Cd. 24-hour 
exposure to Cd in conjunction with iAsIII significantly inhibits GSIS in INS-1 (832/13) β-cells. n = 3; *p < 0.05,  
***p < 0.001 (Metal vs. Control); “$” p < 0.05 (Metal vs. Metal + iAsIII). 
 
 INS-1 (832/13) cells exposed for 24-hours to 1 μM Cd alone displayed a 26% increase in 
insulin secretion compared to untreated cells (Figure 3.4). Exposures to 2 μM and 5 μM Cd 
suggest a downward trend inhibition in percent insulin secretion relative to the 1 μM Cd 
exposure level, but didn’t show significant differences (Figure 3.4). 24-hour exposure to 1 μM 
iAsIII alone resulted in a 48% decrease in insulin secretion. Interestingly, beginning with the 1 
μM iAsIII exposure, co-exposure of increasing Cd concentrations suggests a downward trend in 
inhibition of insulin secretion; however, no differences were statistically significant (Figure 3.4).  
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Figure 3.5: Glucose Stimulated Insulin Secretion following 24-hour exposure to iAsIII and Mn. 24-hour 
exposure to Mn in conjunction with iAsIII and alone significantly inhibits GSIS in INS-1 (832/13) β-cells. n = 3;      
*p < 0.05, ***p < 0.001 (Metal vs. Control); “a” p < 0.05 (Metal vs. iAsIII); “$” p < 0.05 (Metal vs. Metal + iAsIII); 
“%” p < 0.05 (Metal vs. Previous Concentration Metal). 
 
 INS-1 (832/13) cells displayed a 14-fold increase in average percent insulin secretion at 
16.7 mM glucose from that seen at 2.5 mM glucose (Figure 3.5). A 24-hour exposure of cells to  
12.5, 25 and 50 μM Mn alone resulted in a dose-dependent inhibition of average insulin secretion 
by 37%, 62% and 78%, respectively, from that witnessed in the control group (Figure 3.5). 24-
hour exposure to 1 μM iAsIII resulted in a 48% decrease in insulin secretion compared to the 
control group (Figure 3.5). Co-exposure to the aforementioned concentrations of Mn in 
conjunction with 1 μM iAsIII elicited an inhibition of average insulin secretion by 57%, 67% and 
86%, respectively, from that secreted by control cells (Figure 3.5). The average insulin secretion 
for 25 and 50 μM Mn exposures alone did not show significant differences from the insulin 
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secretion from cells co-exposed at identical concentrations of Mn with 1 μM iAsIII; however, 
exposure to 12.5 μM Mn elicited significantly higher amounts of insulin than co-exposure to 
12.5 μM Mn and 1 μM iAsIII (Figure 3.5). Co-exposure of 50 μM Mn and 1 μM iAsIII for 24 
hours resulted in a significant inhibition of average percent insulin secretion compared to that 
resulting from exposure to 1 μM iAsIII alone. 
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Figure 3.6: Glucose Stimulated Insulin Secretion following 24-hour exposure to iAsIII and Zn. 24-hour 
exposure to Zn alone increases GSIS, while co-exposure with iAsIII inhibits GSIS in INS-1 (832/13) β-cells. n ≥ 2;    
*p < 0.05, ***p < 0.001; “$” p < 0.05, “$$$” p < 0.001. 
 
 INS-1 (832/13) cells exhibited a 16-fold increase in average percent insulin secretion at 
16.7 mM glucose from that seen at 2.5 mM glucose (Figure 3.6). 24-hour exposure to 25 μM Zn 
elicited a 27% increase in GSIS compared to that of untreated cells (Figure 3.6). Cells exposed to 
the 6.25 μM Zn and 25 μM Zn concentrations displayed significantly higher insulin secretion 
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than those co-exposed to Zn and iAsIII at identical Zn concentrations (Figure 3.6). 24-hour 
exposure of cells to 1 μM iAsIII alone resulted in a 49% decrease in percent insulin secretion 
compared to untreated cells (Figure 3.6). Co-exposure of Zn and 1 μM iAsIII did not result in any 
significant change in percent insulin secretion compared to that seen in 1 μM iAsIII exposure 
alone (Figure 3.6). 
3.3 Mitochondrial Stress Test after Arsenic and Metal Exposure 
 In order to investigate potential mechanisms of insulin secretion inhibition by Mn, Cd 
and iAsIII, Seahorse XF technology was used to measure mitochondrial OCR in INS-1 (832/13) 
cells. The Seahorse mitochondrial stress test was performed to determine the OCR of β-cells in 
acute high glucose conditions (16.7 mM), and other various modulators of mitochondrial 
function. Response of the β-cells to the mitochondrial stress test trials can be seen in Figures 3.7, 
3.8, 3.10 and 3.11. 
20 
 
0 5 0 1 0 0
0
1 0 0
2 0 0
3 0 0
4 0 0
T im e  (m in u te s )
O
C
R
 (
p
m
o
l/
m
in
)
C o n tro l
1 M  C d
2 M  C d
5 M  C d
1 6 .7  m M  G lu c o s e O lig o m y c in F C C P A n tim y c in  A /R o te n o n e
 
Figure 3.7: Cd Exposure Response to Mitochondrial Stress Test. Mitochondrial Stress Test response of INS-1 
(832/13) cells exposed for 24-hours to Cd alone. n = 3. 
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Figure 3.8: Cd and iAsIII Co-exposure Response to Mitochondrial Stress Test. Mitochondrial Stress Test 
response of INS-1 (832/13) cells co-exposed for 24-hours to Cd and iAsIII alone. n = 3. 
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Figure 3.9: Effects of 24-hour iAsIII and Cd co-exposure on mitochondrial respiration. Inhibition of spare 
respiratory capacity and maximal respiration OCRs by 24-hour Cd and iAsIII co-exposure; n=3; *p ≤ 0.05, ***p ≤ 
0.001 (Metal vs. Control). 
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 The OCR in cells exposed to 1 μM iAsIII during periods of maximal respiration, induced 
by FCCP injection, was significantly decreased to 193 pmol/min compared to the control 
maximal respiration OCR of 290 pmol/min (Figure 3.8 B). 24-hour exposure to 5 μM Cd alone 
significantly decreased the OCR during maximal respiration conditions by 48 pmol/min (Figure 
3.8 B). However, no Cd exposure alone showed a significant difference in OCR allotted as spare 
respiratory capacity in comparison with the control groups (Figure 3.8 C). 24-hour co-exposure 
to 1 μM iAsIII and 1, 2 and 5 μM Cd significantly inhibited maximal respiration (Figure 3.8 B). 
Cells exposed to 1, 2 and 5 μM Cd in conjunction with 1 μM iAsIII displayed maximal 
respiration OCRs of 156, 182 and 159 pmol/min, respectively (Figure 3.8 B). The decreases in 
OCR during maximal respiration translated into significant decreases in spare respiratory 
capacity as well. Compared to the 153 pmol/min OCR observed in untreated cells, a significant 
decrease to 64 pmol/min spare respiratory capacity OCR was seen in cells exposed to 1 μM iAsIII 
alone (Figure 3.8 C). Additionally, cells co-exposed with 1, 2 and 5 μM Cd and 1 μM iAsIII 
exhibited a significant decrease in spare respiratory capacity OCRs to 44, 47 and 45 pmol/min, 
respectively (Figure 3.8 C). Neither non-mitochondrial respiration nor proton leak were 
significantly altered by Cd or iAsIII exposure, indicating the changes in OCR are within the 
mitochondria. 
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Figure 3.10: Mn Exposure Response to Mitochondrial Stress Test. Mitochondrial Stress Test response of INS-1 
(832/13) cells exposed for 24-hours to Mn alone. n = 3. 
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Figure 3.11: Mn and iAsIII Co-exposure Response to Mitochondrial Stress Test. Mitochondrial Stress Test 
response of INS-1 (832/13) cells co-exposed for 24-hours to Mn and iAsIII alone. n = 3. 
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Figure 3.12: Effects of 24-hour iAsIII and Mn co-exposure on mitochondrial respiration. Inhibition of spare 
respiratory capacity and maximal respiration OCRs by 24-hour Mn and iAsIII co-exposure; n=3; *p ≤ 0.05, ***p ≤ 
0.001 (Metal vs. Control). 
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 24-hour exposure of Mn to INS-1 (832/13) β-cells did not result in a significant decrease 
in OCR for most of the parameters investigated. Exposure to 12.5 and 50 μM Mn elicited a 
significant inhibition of OCR during maximal respiration by 62 and 63 pmol/min, respectively 
(Figure 3.9 B); however, these inhibitions did not translate to a significant decrease in spare 
respiratory capacity OCRs (Figure 3.9 C). 24-hour exposure of INS-1 (832/13) cells to 1 μM 
iAsIII alone and in conjunction with 12.5, 25 and 50 μM Mn all significantly decreased maximal 
respiration OCR from the control value by 97, 99, 102 and 124 pmol/min, respectively (Figure 
3.9 B). Exposure to 1 μM iAsIII alone and 12.5, 25 and 50 μM Mn co-exposure with 1 μM iAsIII 
exhibited a significant decrease in spare respiratory capacity OCRs at 89, 80, 78 and 87 
pmol/min, respectively (Figure 3.9 C). Neither non-mitochondrial respiration nor proton leak 
were significantly altered by Mn or iAsIII exposure, indicating the changes in OCR are within the 
mitochondria.  
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CHAPTER 4: DISSCUSION 
 Pancreatic β-cell dysfunction and insulin resistance characterize Type II diabetes. Insulin 
resistance in peripheral tissues overworks β-cells which, over longer periods of time, can result 
in β-cell fatigue and death. Recently, diabetes has been linked to exposure to specific 
environmental toxins. These toxins, including some compounds investigated in this study, may 
disrupt critical points in the insulin secretion pathway and lead to inhibition of insulin secretion 
in β-cells. 
 Low or moderate exposure to iAsIII has been associated with Type II diabetes in human 
populations (Islam et al., 2012). Some studies have shown chronic low level iAsIII exposures 
cause isolated islet and β-cell dysfunction in mice (Douillet et al., 2013; Liu et al., 2014). In vitro 
research using INS-1 (832/13) β-cells has demonstrated 96-hour exposure to 0.5 μM iAsIII 
causing significant inhibition of insulin secretion (Fu et al., 2010). The hypothesized mechanism 
of action for inhibited insulin secretion in the INS-1 (832/13) cells was a change in gene 
transcription, causing altered ROS levels to impact GSIS (Fu et al., 2010). The current study 
attempts to observe the effect of 24-hour iAsIII exposure, as well as that of iAsIII and heavy metal 
co-exposure to the INS-1 (832/13) β-cell line.  
 24-hour exposure of INS-1 (832/13) cells to 1 μM iAsIII resulted in significant inhibition 
of insulin secretion without large changes in cell viability. This removes the possibility of 
cytotoxicity solely being responsible for the observed inhibition of insulin secretion. A previous 
study in isolated islets indicated 48-hour iAsIII exposure does not result in significant changes to 
islet insulin content, but instead severely inhibits the amount of insulin secreted by the islet 
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(Douillet et al., 2013). This suggests the reason for the observed inhibition of insulin secretion is 
due to disruption of insulin secretion machinery rather than decreased insulin biosynthesis. 
 There are currently many hypothesized targets of iAsIII within the insulin secretion 
pathway (Figure 1.1) based on studies in other cell types. As seen in Figure 1.1, iAsIII and its 
methylated metabolite (MAsIII) have been identified as possible modulators for many key steps 
in the insulin secretion pathway. Any of these identified steps could be a potential player in the 
inhibition of insulin secretion observed in the current study. 
 Along with iAsIII, Cd is another naturally-occurring environmental compound proposed 
to have toxic effects on the body (CDC, 2012). In certain regions, iAsIII and Cd have been found 
together in surface soils at high concentrations (Diawara et al., 2006). Other studies have also 
shown associations between increased urinary Cd and Type II diabetes incidence (Schwartz et 
al., 2003). One in vitro study went further and showed 72-hour Cd exposure to MIN6 β-cells 
resulting in Cd accumulation and inhibition of insulin secretion (El Muayed et al., 2012).  
 After a 24-hour exposure to 1 μM Cd alone, INS-1 (832/13) cells exhibited a significant 
increase in insulin secretion. There is no clear reason for the increase in insulin secretion. Both 
subsequent Cd exposure levels resulted in a downward trend in insulin secretion, but with no 
significant difference compared to untreated β-cells. This would suggest higher concentrations of 
Cd may cause significant inhibition of insulin secretion. 24-hour co-exposure of 1, 2 and 5 μM 
Cd and 1 μM iAsIII to the INS-1 (832/13) cells inhibited insulin secretion to similar levels 
observed at 1 μM iAsIII exposure alone. This suggests iAsIII acts as the primary driver of insulin 
secretion when co-exposed with the tested concentrations of Cd. 
 Chronic Mn exposure also inhibited GSIS of INS-1 cells in a dose-dependent manner 
without a significant decrease in cell viability. Interestingly, a downward trend in insulin 
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secretion is seen in the 24-hour Mn and iAsIII co-exposure groups with increasing Mn 
concentrations. It is important to note that co-exposure of 12.5 μM Mn and 1 μM iAsIII elicited a 
more potent inhibition of insulin secretion than that from 12.5 μM Mn alone; however, 24-hour 
exposure of cells to 25 and 50 μM Mn alone did not significantly differ from groups co-exposed 
to Mn and iAsIII at identical concentrations. This suggests that Mn-induced inhibition of insulin 
secretion overpowers that by iAsIII at higher concentrations, which identifies chronic Mn 
exposure as a potent inhibitor of GSIS. 
 Although Mn is identified as a heavy metal with many physiological uses in activating 
enzymes, not much is specifically known about its role in β-cell function. One study showed in 
vivo Mn supplementation could be protective against diet-induced diabetes by enhancing insulin 
secretion in islets (Lee et al. 2013). However, these results are contrary to those observed in the 
current study, exhibiting a severe dose-dependent inhibition of insulin secretion in INS-1 
(832/13) β-cells following 24-hour Mn exposure. The differences seen between the two studies 
may be due to discrepancies in doses and differences of in vivo versus in vitro Mn exposure. 
  Similar to Cd, Mn and Ca fluxes in pancreatic β-cells have been shown to compete in the 
presence of D-glucose (Rorsman and Hellman, 1983). It is worth noting, however, that the study 
used 2.5 mM Mn2+ and 1.28 mM Ca2+ medium, which has a much greater concentration of Mn2+ 
than that used in the current study. For this reason, Mn-induced inhibition of insulin secretion 
observed in the INS-1 (832/13) cells is most likely not due to competition between Mn and Ca 
fluxes, due to the large ratio of Ca2+ to Mn2+ ions present in the SAB utilized in GSIS trials. 
Future studies will need to focus on evaluating the impact of Mn exposure on Ca changes within 
β-cells. 
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 Unlike Cd or Mn, Zn has an identified role in β-cell function. Zn plays a role in insulin 
production, insulin crystallization for proper storage, Zn finger-dependent gene regulation and 
insulin granule translocation to the membrane for exocytosis (Li, 2014). One study using Zn 
supplementation on INS-1E β-cells found a significant increase in insulin secretion for 
concentrations up until 30 μM Zn (Nygaard et al., 2014). Thus, it was hypothesized that Zn 
supplementation could combat the inhibitory effects of iAsIII exposure on insulin secretion by the 
β-cell. In agreement with Nygaard’s study, a significant increase in insulin secretion compared to 
untreated β-cells was observed in the 25 μM Zn exposure group. Nevertheless, there was no 
significant increase in insulin secretion when the same Zn exposures were co-exposed with 1 μM 
iAsIII. These results identify iAsIII as the primary driver of reduced insulin secretion when found 
in mixture with Zn at the tested concentrations. 
 Recent studies have identified mitochondria as a target for environmental toxins, 
especially those with a cationic nature like Cd and Mn. Due to their divalent nature, it has been 
shown that both can accumulate within mitochondria in various tissues (Meyer et al., 2013; 
Rorsman et al., 1982). This is of special importance to studies exploring the effects of chronic 
exposures to these metals as lower exposure concentrations may induce significant effects over 
time. Cd, Mn and As have all been identified as possible mitochondrial toxicants (Meyer et al., 
2013). Referring back to Figure 1.1, ATP production by mitochondria is a critical step in the 
insulin secretory pathway. Thus, it was hypothesized that iAsIII, Cd and Mn may be inhibiting 
insulin secretion by causing β-cell mitochondrial dysfunction. 
 24-hour exposure to 12.5 and 50 μM Mn alone inhibited maximal respiration OCR. 
However, with the effects of Mn on mitochondrial function being minimal and in no identifiable 
trend, the explanation for why Mn drastically inhibits insulin secretion in a dose-dependent 
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fashion seems to lie elsewhere in the insulin secretion pathway. Additionally, Mn and iAsIII co-
exposure inhibited mitochondrial function much more severely than Mn alone at the tested 
concentrations; however, the GSIS trials showed no difference in the amount of insulin secreted. 
This means that the primary mechanism of inhibition of insulin release by Mn is not in the ETC. 
 Contrary to Mn exposure, 5 μM Cd exposure alone did inhibit OCR during maximal 
respiration conditions. Inhibition of OCR in β-cells exposed to 5 μM Cd after FCCP injection 
mean the cells would not be able to respond as effectively during physiological condition of high 
energy demand. Since maximal respiration conditions were induced by FCCP, an inner 
mitochondrial membrane decoupler acting after Complex V in the ETC, it is difficult to 
determine which complex is being acted upon by Cd to elicit the inhibition of OCR.  
 When Cd and Mn treatments were administered in conjunction with 1 μM iAsIII, there 
was a drastic inhibition of maximal respiration and spare respiratory capacity OCR in the INS-1 
(832/13) β-cells. As previously mentioned, due to the location of FCCP uncoupling, iAsIII can be 
acting on any of the ETC complexes. One recent study identified MAs and DMAs, methyl 
metabolites of As, as inhibitors of ETC complexes in rat hepatocytes, suggesting a possibility for 
iAsIII acting as an inhibitor of one or more ETC complexes in INS-1 (832/13) cells 
(Naranmandura et al., 2011). An inhibition of spare respiratory capacity again indicates that 24-
hour 1 μM iAsIII renders β-cells unable to function efficiently under energy-demanding 
situations. However, even with a severe decrease in OCR available as spare respiratory capacity, 
no significant decrease in the amount of OCR going towards ATP production was observed. 
 This study found that 24-hour Cd exposure to INS-1 (832/13) β-cells results in a 
downward trend in insulin secretion without significant declines in cell viability. 24-hour Mn 
exposure, on the other hand, elicited a dose-dependent inhibition of insulin secretion, while Zn 
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exposure over the same period of time increased insulin release at a specific concentration. Co-
exposure studies for the metals showed iAsIII as the primary driver of insulin secretion inhibition 
with the tested concentrations of Cd and Zn; however, at higher concentrations, 24-hour Mn and 
iAsIII co-exposure showed an overpowering inhibitory effect of Mn over iAsIII. Additionally, 24-
hour iAsIII exposure, alone and in conjunction with the heavy metals, exhibited significant 
inhibition of maximal respiration OCR. Cd exposure alone also elicited an inhibition in maximal 
respiration OCR at the highest tested concentration. Mn exposure alone also showed inhibitory 
effects on maximal respiration however, not enough to explain the massive decreases in insulin 
secretion observed during the GSIS trials. This demonstrates that Mn and iAsIII primarily inhibit 
insulin secretion via actions on separate portions of the insulin secretory pathway. 
In addition to the recognized effects of iAsIII exposure, chronic Cd and Mn exposures 
also show relevance in pancreatic β-cell dysfunction. Unfortunately, most research on the topic 
of Mn and Cd effects on β-cells uses high concentrations of the metals that could result in 
cytotoxicity. Further research using lower concentrations of these metals and chronic exposure 
times would better resemble real world exposures. Future studies on the effects of iAsIII, Mn and 
Cd on insulin secretion and their respective mechanisms should be carried out using isolated 
islets or an in vivo model. The use of either would allow a better representation of how 
interactions between compounds may be affecting β-cells and peripheral tissues.  
Diabetes is a health concern worldwide and should be treated with the utmost importance. 
With increasing evidence of associations between environmental compound exposure and 
diabetes prevalence, especially in industrializing countries, it is crucial to further investigate this 
topic. Occurrence of these compounds is rarely ever alone, with complex mixtures many times 
found in surface soils (Diawara et al., 2006). This thesis sought to address the impact of heavy 
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metal co-exposures in the context of pancreatic β-cell function. Overall, it was determined that 
heavy metal co-exposures can increase the diabetogenic potential of iAsIII exposure, which could 
aid in understanding DM occurrence in human populations worldwide. Interactions between 
compounds exist and should be further studied to gain a better understanding of how they can 
affect the body. 
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